Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Bexagliflozin Efficacy and Safety Trial

ClinicalTrials.gov ID: NCT02558296

Public ClinicalTrials.gov record NCT02558296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 8:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double Blind Placebo Controlled Study to Evaluate the Effects of Bexagliflozin on Hemoglobin A1c in Patients With Type 2 Diabetes and Increased Risk of Cardiovascular Adverse Events

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM) and increased risk of cardiovascular adverse events. The data from this study will be combined with the data from other bexagliflozin studies in a meta-analysis of CV safety outcomes.

Study identification

NCT ID
NCT02558296
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Theracos
Industry
Enrollment
1,700 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2015 (Actual)
Primary completion
Aug 2018 (Actual)
Completion
Oct 23, 2019 (Actual)
Last update posted
Jul 14, 2021

2015 – 2019

United States locations

U.S. sites
66
U.S. states
30
U.S. cities
60
Facility City State ZIP Site status
Research Site 1090 Gilbert Arizona 85295 —
Research Site 1041 Little Rock Arkansas 72204 —
Research Site 1073 Azusa California 91773 —
Research Site 1076 Concord California 94520 —
Research Site 1078 Fresno California 93720 —
Research Site 1089 Harbor City California 90710 —
Research Site 1058 Lincoln California 95821 —
Research Site 1051 Los Angeles California 90022 —
Research Site 1004 Los Angeles California 90057 —
Research Site 1068 Montclair California 91763 —
Research Site 1077 Orange California 92868 —
Research Site 1218 Denver Colorado 80209 —
Research Site 1092 Golden Colorado 80401 —
Research Site 1216 Norwalk Connecticut 06851 —
Research Site 1083 Newark Delaware 19713 —
Research Site 1057 Boca Raton Florida 33434 —
Research Site 1059 Brooksville Florida 34601 —
Research Site 1050 Panama City Florida 32401 —
Research Site 1099 Port Charlotte Florida 33952 —
Research Site 1066 Tampa Florida 33634 —
Research Site 1072 Augusta Georgia 30909 —
Research Site 1082 Pocatello Idaho 83201 —
Research Site 1258 Champaign Illinois 61822 —
Research Site 1043 Anderson Indiana 46011 —
Research Site 1071 Avon Indiana 46123 —
Research Site 1086 Des Moines Iowa 50314 —
Research Site 1224 Covington Kentucky 41011 —
Research Site 1228 Annapolis Maryland 21401 —
Research Site 1221 Baltimore Maryland 21202 —
Research Site 1079 Hyattsville Maryland 20782 —
Research Site 1223 Midland Michigan 48670 —
Research Site 1217 Petoskey Michigan 49770 —
Research Site 1254 Ypsilanti Michigan 48197 —
Research Site 1054 St Louis Missouri 63136 —
Research Site 1060 St Louis Missouri 63141 —
Research Site 1252 Kalispell Montana 59901 —
Research Site 1052 Omaha Nebraska 68131 —
Research Site 1263 Omaha Nebraska 68198 —
Research Site 1080 Las Vegas Nevada 89123 —
Research Site 1219 Somerset New Jersey 08873 —
Research Site 1044 Albuquerque New Mexico 87102 —
Research Site 1220 Saratoga Springs New York 12866 —
Research Site 1264 The Bronx New York 10468 —
Research Site 1049 West Seneca New York 14224 —
Research Site 1085 Chapel Hill North Carolina 27517 —
Research Site 1074 Charlotte North Carolina 28204 —
Research Site 1056 Morehead City North Carolina 28557 —
Research Site 1229 Wilmington North Carolina 28401 —
Research Site 1064 Winston-Salem North Carolina 27103 —
Research Site 1075 Fargo North Dakota 58103 —
Research Site 1266 Lindsay Oklahoma 73052 —
Research Site 1055 Oklahoma City Oklahoma 73119 —
Research Site 1265 Oklahoma City Oklahoma 73134 —
Research Site 1046 Oklahoma City Oklahoma 73135 —
Research Site 1260 Lancaster Pennsylvania 17601 —
Research Site 1042 Cumberland Rhode Island 02864 —
Research Site 1225 Austin Texas 78758 —
Research Site 1259 Dallas Texas 75235 —
Research Site 1048 Kingwood Texas 77339 —
Research Site 1070 Lampasas Texas 76550 —
Research Site 1222 Lewisville Texas 75067 —
Research Site 1081 North Richland Hills Texas 76180 —
Research Site 1226 San Antonio Texas 78212 —
Research Site 1053 San Antonio Texas 78218 —
Research Site 1063 Salt Lake City Utah 84124 —
Research Site 1230 Salem Virginia 24153 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02558296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2021 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02558296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →